Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Cohen: Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders. (0.11 sec) 

Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective …

- diabetesjournals.org
D Cohen, RP Stolk, DE Grobbee, CC Gispen-de … - Diabetes care, 2006 - Am Diabetes Assoc
RESULTS—The mainly Western European (87.7%) study population had a mean age of 40.8
years, was 70% male, and had a mean fasting glucose of 5.1 mmol/l and a mean fasting insulin
of 14.8 mU/l. Hyperglycemia was present in 7% of the population: 1.5% with impaired ...
Cited by 30 - Related articles - BL Direct - All 8 versions

Schizophrenia, antipsychotics and diabetes: genetic aspects


F Bellivier - European Psychiatry, 2005 - Elsevier
The relatively high comorbidity of type 2 diabetes and schizophrenia may suggest a shared biological
susceptibility to these twoconditions. Family studies have demonstrated an increased risk of
diabetes in unaffected relatives of patients with schizophrenia, consistent with a heritable ...
Cited by 18 - Related articles - All 4 versions

Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective …

- diabetesjournals.org [PDF] 
RD Jindal, MS Keshavan - Diabetes care, 2007 - Am Diabetes Assoc
W e thank Kanna and Abreu- Pacheco (1) for their comments on our study (2). As Kanna and
Abreu-Pacheco point out, overweight and obesity are strongly linked to the develop- ment of
type 2 diabetes and can compli- cate its management. While most patients with type 2 ...
Cited by 2 - Related articles - BL Direct - All 6 versions

Are there specific care requirements for patients with schizophrenia and diabetes …


P Thomas, P Raymondet, B Charbonnel, G Vaiva - European Psychiatry, 2005 - Elsevier
An interactive workshop was held to discuss the risk of diabetes in patients with
schizophrenia, to evaluate the available data concerninghow such patients should be managed
in terms of minimising the risk of diabetes and of optimising their care where diabetes to ...
Cited by 4 - Related articles - All 4 versions

Insulin resistance and adiponectin levels in drug-free patients with schizophrenia: …


K Wolf, R Mass, F Kiefer, K Wiedemann, D … - Canadian Journal of …, 2006 - server03.cpa-apc.org
Objective: To compare the insulin sensitivity and adiponectin levels of medication-free patients
suffering from schizophrenia or schizoaffective disorder with that of matched healthy
volunteers. ... Methods: We evaluated 9 nondiabetic patients aged 26.6 years (median 26 ...
Cited by 26 - Related articles - Cached - BL Direct - All 8 versions

A prospective study of monitoring practices for metabolic disease in antipsychotic- …


P Mackin, DR Bishop, HMO Watkinson - BMC psychiatry, 2007 - biomedcentral.com
A high prevalence of undiagnosed and untreated metabolic disease was present at baseline
assessment. Mean follow-up time was 599.3 (SD ± 235.4) days. Body mass index (p <
0.005) and waist circumference (p < 0.05) had significantly increased at follow-up, as had ...
Cited by 9 - Related articles - Cached - All 7 versions

Glucose metabolism in patients with schizophrenia treated with olanzapine or …


DC Henderson, PM Copeland, CP Borba, TB … - Journal of Clinical …, 2006 - 万方数据资源系统
OBJECTIVE: Clozapine and olanzapine treatment has been associated with insulin resistance
in non-obese schizophrenia patients. Much less is known regarding other agents such as
quetiapine. The objective of this study was to compare matched olanzapine- and ...
Cited by 20 - Related articles - BL Direct - All 3 versions

[PDF] Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia


LM Spelman, PI Walsh, N Sharifi, P Collins, JH Thakore - Diabetic Medicine, 2007 - epubs.rcsi.ie
Use Licence Attribution-NonCommercial-ShareAlike 1.0 You are free: • to copy, distribute,
display, and perform the work • to make derivative works Under the following conditions: •
Attribution. You must give the original author credit. • Non-Commercial. You may not use ...
Cited by 24 - Related articles - BL Direct - All 5 versions

A UK audit of screening for the metabolic side effects of antipsychotics in …

- oxfordjournals.org
TRE Barnes, C Paton, MR Cavanagh, E Hancock, DM … - Schizophrenia Bulletin, 2007 - MPRC
Reviews of the association between psychotic disorder, the metabolic syndrome, diabetes, and
antipsychotic drugs conclude that there is a need for active, routine physical health screening
of patients' prescribed antipsychotic drugs. From published guidelines, we derived the ...
Cited by 13 - Related articles - BL Direct - All 3 versions

Schizophrenia and comorbid metabolic disorders.


DC Henderson - The Journal of clinical psychiatry, 2005 - ncbi.nlm.nih.gov
Comorbid metabolic disorders in patients with schizophrenia are underrecognized by many health
care professionals and patients. That lack of awareness can contribute to serious morbidity and
mortality in patients with schizophrenia. Patients with schizophrenia may be at greater risk ...
Cited by 39 - Related articles - BL Direct - All 2 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google